NUDT1在肝细胞癌中的表达特征、预后价值及促癌作用机制研究OA
Expression characteristics,prognostic significance,and tumor-promoting mechanisms of NUDT1 in hepatocellular carcinoma
背景与目的:肝细胞癌(HCC)具有高度侵袭性和较高的复发率,寻找新的分子标志物及治疗靶点对于改善患者预后具有重要意义.核糖核酸脱磷酸酶1(NUDT1)参与氧化应激调控和DNA损伤修复过程,在多种恶性肿瘤中呈异常表达,但其在HCC发生、发展中的作用及潜在机制尚未明确.本研究旨在探讨NUDT1在HCC中的表达特征、预后价值及其对肿瘤细胞生物学行为的影响. 方法:基于癌症基因组图谱(TCGA)、基因表达综合数据库(GEO)及RNA测序数据筛选HCC相关候选基因,采用生物信息学方法分析NUDT1表达水平、诊断效能及与患者预后的关系.收集60例HCC患者临床组织样本,通过免疫组织化学染色验证NUDT1蛋白表达,并分析其与临床病理特征及生存结局的相关性.构建NUDT1稳定敲低HepG2细胞株和稳定过表达LM3细胞株,采用qRT-PCR、Western blot验证转染效率,通过CCK-8法和克隆形成实验检测细胞增殖,通过划痕实验、Transwell迁移及侵袭实验检测细胞迁移和侵袭能力,通过流式细胞术检测细胞凋亡,探讨NUDT1对HCC细胞生物学行为的影响,并利用PI3K/Akt信号通路激动剂及抑制剂进行机制验证. 结果:生物信息学分析显示,NUDT1在HCC组织中呈高表达,并与患者较差的总体生存期、疾病特异性生存期及无进展间期相关.临床样本验证发现,NUDT1蛋白在HCC组织中的表达明显高于癌旁组织,且高表达与TNM分期、肿瘤直径及血管侵犯相关.细胞功能实验显示,敲低NUDT1可显著抑制HCC细胞增殖、迁移和侵袭,并促进细胞凋亡;而过表达NUDT1则产生相反作用.进一步研究发现,激活PI3K/Akt信号通路可部分逆转NUDT1敲低引起的抑癌效应,而抑制该通路可削弱NUDT1过表达促进肿瘤进展的作用. 结 论:NUDT1在HCC中异常高表达,并与患者不良预后相关.NUDT1可能通过激活PI3K/Akt信号通路促进HCC细胞增殖、迁移和侵袭,是潜在的预后标志物和治疗靶点.
Background and Aims:Hepatocellular carcinoma(HCC)is characterized by high malignancy,invasiveness,and recurrence rates.Identification of novel molecular biomarkers and therapeutic targets is essential for improving patient outcomes.Nudix hydrolase 1(NUDT1),a key regulator involved in oxidative stress response and DNA damage repair,has been reported to be dysregulated in various cancers;however,its role in HCC remains unclear.This study aimed to investigate the expression pattern,prognostic significance,and biological function of NUDT1 in HCC. Methods:RNA sequencing data from The Cancer Genome Atlas(TCGA),Gene Expression Omnibus(GEO),and clinical samples were analyzed using bioinformatics approaches to identify HCC-associated genes.The expression level,diagnostic performance,and prognostic value of NUDT1 were evaluated.Immunohistochemistry was performed on 60 paired HCC and adjacent normal tissues to validate NUDT1 expression and analyze its association with clinicopathological characteristics and survival outcomes.Stable NUDT1-knockdown HepG2 cells and NUDT1-overexpressing LM3 cells were established.Cell proliferation,colony formation,migration,invasion,and apoptosis were evaluated using the CCK-8 assay,colony formation assay,wound healing assay,Transwell assay,and flow cytometry.The involvement of the PI3K/Akt signaling pathway was further examined using pathway agonists and inhibitors. Results:NUDT1 was significantly upregulated in HCC tissues and was associated with poor overall survival,disease-specific survival,and progression-free interval.Immunohistochemical analysis confirmed increased NUDT1 protein expression in HCC tissues,which was correlated with TNM stage,tumor size,and vascular invasion.Functional assays demonstrated that NUDT1 knockdown inhibited HCC cell proliferation,migration,and invasion while promoting apoptosis,whereas NUDT1 overexpression exerted opposite effects.Mechanistically,activation of the PI3K/Akt pathway partially reversed the inhibitory effects induced by NUDT1 knockdown,while PI3K/Akt inhibition attenuated the tumor-promoting effects of NUDT1 overexpression. Conclusion:NUDT1 is highly expressed in HCC and associated with poor prognosis.NUDT1 promotes HCC progression through activation of the PI3K/Akt signaling pathway and may serve as a potential prognostic biomarker and therapeutic target.
陈勇治;彭睿;周宁;刘韦男;王冠武;刘文;李嘉欣;黄怀银
湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005||扬州大学附属苏北人民医院 肝胆外科,江苏 扬州 225009湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005湖南师范大学附属第一医院(湖南省人民医院)肝胆外科,湖南 长沙 410005
医药卫生
癌,肝细胞Nudix水解酶预后细胞增殖肿瘤浸润
Carcinoma,HepatocellularNudix HydrolasesPrognosisCell ProliferationNeoplasm Invasiveness
《中国普通外科杂志》 2026 (7)
1364-1375,12
湖南省教育厅科学研究基金资助项目(25C0006,23B0055).
评论